Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Keratin 18 pseudogene 13 (KRT18P13) is a noncoding, processed pseudogene related to the functional keratin 18 gene. It is dispersed in the genome as one of the numerous pseudogenes that share sequence similarity to keratin 18 but lack an intact reading frame, and is not transcribed into a functional protein. There is no evidence for direct involvement in cellular processes, disease, or drug response. The functional protein encoded by the related KRT18 gene is a type I intermediate filament important in epithelial tissue structure, cell cycle regulation, apoptosis, and is a biomarker in several cancers, but KRT18P13 itself does not share these properties and is not considered a biological or pharmacological target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Keratin 18 pseudogene 13 (KRT18P13).